leadf
logo-loader
viewTodos Medical Ltd.

Todos Medical is launching testing in Europe and Israel, in the next six to eight months

Todos Medical (OTCMKTS:TOMDF) CEO Herman Weiss sits down with Proactive Investors' Steve Darling at the 9th Annual LD Micro Invitational Investor Conference in Los Angeles, CA. The Israel based, cancer in-vitro-diagnostic company focuses on creating a methodology for cancer detection tests that are accessible, affordable, and accurate.

Quick facts: Todos Medical Ltd.

Price: 0.0792 USD

OTCQB:TOMDF
Market: OTCQB
Market Cap: $15.75 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Todos Medical Ltd. named herein, including the promotion by the Company of Todos Medical Ltd. in any Content on the Site, the Company receives...

FOR OUR FULL DISCLAIMER CLICK HERE

Todos Medical reveals positive clinical proof of concept data from its rapid...

Todos Medical Ltd (OTCQB:TOMDF) CEO Gerald Commissiong tells Proactive the group has “positive clinical proof of concept data” from its lab-based rapid SARS-CoV-2 3CL protease diagnostic test in collaboration with its joint venture partner NLC Pharma. Commissiong says now, the group is...

2 weeks ago

2 min read